Keyphrases
Epilepsy Surgery
100%
Pediatric Patients
53%
Pediatric Refractory Epilepsy
46%
Spiking Activity
46%
CD4+CD25+ Regulatory T Cells
46%
Myeloid-derived Suppressor Cells
46%
CD14+
46%
Dendritic Cells
46%
Seizure Frequency
46%
Hemispherectomy
46%
Diagnostic Tool
46%
Cognitive Function
46%
Remifentanil
46%
Multiple Myeloma
46%
Denmark
46%
Antiseizure Medication
46%
HLA-DR
46%
Callosotomy
46%
Intelligence Quotient
46%
Intraoperative Assessment
23%
Working Diagnosis
23%
Temporal Lobe Epilepsy
23%
Medication Use
19%
Antiepileptic Drugs
19%
Regulatory T (Treg) Cells
17%
Monoclonal Gammopathy of Undetermined Significance
17%
Remission
17%
Developmental Quotient
13%
Postoperative Seizure
13%
Significant Predictors
13%
IQ Change
13%
Drug-resistant Epilepsy
13%
Immune Therapy
11%
Cognitive Evaluation
6%
Recurrent Seizures
6%
Pediatric Drug-resistant Epilepsy
6%
Follow-up Time
6%
Cognitive Ability
6%
Beneficial Effects
6%
Medical Charts
6%
Surgical Control
6%
Seizure Control
6%
Cognitive Functioning
6%
2-year Follow-up
6%
Median Time
6%
Pediatric Epilepsy Surgery
6%
Seizure Freedom
6%
Cognitive Outcome
6%
Non-surgical
6%
Epilepsy Onset
6%
Medicine and Dentistry
Epilepsy Surgery
93%
Pediatrics Patient
46%
Cognition
46%
Intelligence Quotient
46%
Remifentanil
46%
Diagnosis
46%
Epileptic Seizure
33%
Mesial Temporal Lobe Epilepsy
23%
Anticonvulsant
19%
Drug Resistant Epilepsy
13%
Drug Therapy
13%
Pediatrics
6%
Cognitive Function
6%
Brain Development
6%
Pediatric Epilepsy
6%
Immunology and Microbiology
FOXP3
46%
HLA-DR
46%
Myeloid-Derived Suppressor Cell
46%
CD14
46%
Dendritic Cell
46%
Multiple Myeloma
46%
CD4
46%
Regulatory T Cell
46%
Monoclonal Immunoglobulinemia
17%
Immunotherapy
11%
Myeloid
5%
Dendritic Cell Function
5%
Humoral Immunity
5%
T-Helper Cell
5%
Immune System
5%
T Cell
5%
Cytotoxic T-Cell
5%
